+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cytomegalovirus Tests Market - Global Forecast 2026-2032- Product Image
Cytomegalovirus Tests Market - Global Forecast 2026-2032- Product Image
New

Cytomegalovirus Tests Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 187 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5968363
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The cytomegalovirus tests market is experiencing a pivotal period of transformation as diagnostic stakeholders face shifting clinical requirements, emerging technologies, and new operational complexities. Senior decision-makers must leverage robust market intelligence to guide strategic choices and foster sustainable growth in this vital diagnostics segment.

Market Snapshot: Cytomegalovirus Tests Market Trends

The cytomegalovirus tests market grew from USD 731.24 million in 2025 to USD 788.11 million in 2026. Projected to sustain a CAGR of 8.47%, it is anticipated to reach USD 1.29 billion by 2032. Ongoing developments within the sector are influenced by advances in test modalities, evolving testing strategies in clinical environments, and strengthening supply chain infrastructure. These factors are converging to reshape commercial models and accelerate the adoption of innovative diagnostic approaches, particularly in settings where clinical urgency and operational efficiency are critical for success.

Scope & Segmentation Overview

This comprehensive analysis details the evolving diagnostic landscape for cytomegalovirus, with a spotlight on core trends affecting adoption and implementation. Segmentation of the market covers:

  • Product Modalities: Encompasses antigen detection technologies such as immunofluorescence and lateral flow assays, nucleic acid amplification techniques like digital PCR and real-time PCR, and serological platforms including chemiluminescent immunoassays and ELISA. These innovations are meeting diverse clinical demand for accuracy, throughput, and point-of-care adaptability.
  • Test Types: Incorporates both qualitative and quantitative diagnostic formats, allowing tailored deployment for frontline screening as well as monitoring and confirmation in advanced laboratory settings.
  • Applications: Addresses requirements spanning diagnostic confirmation, donor and prenatal screening procedures, and broader public health and epidemiological surveillance programs.
  • End Users: Includes clinics, diagnostic laboratories, hospitals, and research institutes, each facing unique operational and infrastructure considerations that shape technology procurement and implementation.
  • Sample Matrices: Offers collection flexibility through saliva, tissue, urine, or whole blood sampling, expanding accessibility and supporting less invasive diagnostic pathways for patients and providers.
  • Regions: The market is segmented across the Americas, Europe, Middle East and Africa, and Asia-Pacific, reflecting differences in regulatory requirements, healthcare infrastructure, and levels of diagnostic adoption.

Cytomegalovirus Tests Market: Key Takeaways for Senior Leaders

  • Escalating demand for rapid and actionable diagnostic solutions is evident, especially in high-risk clinical populations. Decision-makers are prioritizing tools that deliver both speed and quantitative accuracy to support effective patient management.
  • The integration of high-throughput nucleic acid techniques alongside decentralized antigen and serological test platforms is creating strategic versatility for both screening and confirmatory workflows.
  • Efforts to reinforce supply chain continuity—such as diversifying suppliers, expanding local manufacturing, and renegotiating contracts—play a central role in risk mitigation and cost control amid evolving trade dynamics.
  • Highly varied regulatory frameworks and payer models across major global regions necessitate customized product validation strategies, ensuring successful go-to-market and clinical adoption pathways.
  • Active pursuit of collaborations, licensing agreements, and bundled diagnostic service models is driving broader product adoption, portfolio diversification, and improved alignment with the needs of labs and healthcare organizations.

Tariff Impact: Supply Chain and Cost Strategies

Recent changes in United States tariff policy have prompted diagnostic manufacturers to overhaul sourcing and production workflows. The sector’s response includes ramping up supplier diversity, boosting domestic manufacturing, and renegotiating procurement contracts to contain cost volatility and secure uninterrupted access to critical reagents. These moves help support consistent cytomegalovirus diagnostic testing volumes despite uncertainties associated with shifting global trade conditions.

Methodology & Data Sources

Multi-method triangulation underpins this analysis. Structured reviews of peer-reviewed literature and regulatory filings complement primary interviews with laboratory directors, procurement specialists, and industry executives. Every market segment is validated for both clinical significance and operational relevance, with findings verified through cross-referencing technical and regulatory documentation to ensure data integrity and reliability.

Why This Report Matters

  • Enables leadership teams to optimize product portfolios by aligning investment with advances in core diagnostic technologies and emerging clinical priorities.
  • Presents actionable insights to refine procurement, supply chain, and regulatory strategies in response to changing regional and global circumstances.
  • Supports the adaptation of commercialization and clinical adoption tactics so organizations can maintain competitiveness as the diagnostics landscape shifts.

Conclusion: Strategic Direction in Cytomegalovirus Diagnostics

Market leadership in cytomegalovirus diagnostics will rest on astute alignment of technological investments, segmentation focus, and supply chain resilience. Targeted strategies for product validation, regulatory navigation, and stakeholder education are critical to capturing ongoing clinical and commercial value as the sector continues to evolve.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Cytomegalovirus Tests Market, by Product
8.1. Antigen Detection Test
8.1.1. Immunofluorescence Assay
8.1.2. Lateral Flow Assay
8.2. Nucleic Acid Amplification Test
8.2.1. Digital Polymerase Chain Reaction
8.2.2. Isothermal Amplification
8.2.3. Real Time Polymerase Chain Reaction
8.3. Serological Assay
8.3.1. Chemiluminescent Immunoassay
8.3.2. Enzyme Linked Immunosorbent Assay
8.3.3. Lateral Flow Immunoassay
9. Cytomegalovirus Tests Market, by Test Type
9.1. Qualitative
9.2. Quantitative
10. Cytomegalovirus Tests Market, by Sample Type
10.1. Saliva
10.2. Tissue
10.3. Urine
10.4. Whole Blood
11. Cytomegalovirus Tests Market, by Application
11.1. Diagnostic
11.2. Donor Screening
11.3. Prenatal Testing
11.4. Screening
12. Cytomegalovirus Tests Market, by End User
12.1. Clinic
12.2. Diagnostic Laboratory
12.3. Hospital
12.4. Research Institute
13. Cytomegalovirus Tests Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Cytomegalovirus Tests Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Cytomegalovirus Tests Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Cytomegalovirus Tests Market
17. China Cytomegalovirus Tests Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Abbexa Ltd.
18.6. Abbott Laboratories
18.7. Accubiotech Co., Ltd
18.8. AdvaCare Pharma USA
18.9. Agilent Technologies, Inc.
18.10. Atlas Medical GmbH
18.11. Bio-Rad Laboratories, Inc.
18.12. Biogenix Inc. Pvt. Ltd.
18.13. CLONIT srl
18.14. Creative Diagnostics
18.15. CTK Biotech Inc. by SSI Diagnostica A/S
18.16. Diasorin S.p.A.
18.17. Elabscience Bionovation Inc.
18.18. F. Hoffmann-La Roche Ltd.
18.19. Hangzhou Realy Tech Co., Ltd.
18.20. Intec Products, Inc.
18.21. IQ Products B.V.
18.22. Jiangsu Macro & Micro-Test Med-Tech Co., Ltd.
18.23. Meridian Bioscience, Inc. by SD Biosensor
18.24. Thermo Fisher Scientific Inc
List of Figures
FIGURE 1. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL CYTOMEGALOVIRUS TESTS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES CYTOMEGALOVIRUS TESTS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA CYTOMEGALOVIRUS TESTS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY IMMUNOFLUORESCENCE ASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY IMMUNOFLUORESCENCE ASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY IMMUNOFLUORESCENCE ASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY LATERAL FLOW ASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY LATERAL FLOW ASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY LATERAL FLOW ASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY DIGITAL POLYMERASE CHAIN REACTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY DIGITAL POLYMERASE CHAIN REACTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY DIGITAL POLYMERASE CHAIN REACTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY REAL TIME POLYMERASE CHAIN REACTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY REAL TIME POLYMERASE CHAIN REACTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY REAL TIME POLYMERASE CHAIN REACTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY QUALITATIVE, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY QUALITATIVE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY QUALITATIVE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY QUANTITATIVE, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY QUANTITATIVE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY QUANTITATIVE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SALIVA, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SALIVA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SALIVA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TISSUE, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TISSUE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TISSUE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY URINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY URINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY URINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY WHOLE BLOOD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY WHOLE BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY DIAGNOSTIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY DIAGNOSTIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY DONOR SCREENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY DONOR SCREENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY DONOR SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRENATAL TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRENATAL TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRENATAL TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SCREENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SCREENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY CLINIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY CLINIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY DIAGNOSTIC LABORATORY, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY DIAGNOSTIC LABORATORY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY DIAGNOSTIC LABORATORY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY RESEARCH INSTITUTE, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY RESEARCH INSTITUTE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY RESEARCH INSTITUTE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. AMERICAS CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 87. AMERICAS CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 88. AMERICAS CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2032 (USD MILLION)
TABLE 89. AMERICAS CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2032 (USD MILLION)
TABLE 90. AMERICAS CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2032 (USD MILLION)
TABLE 91. AMERICAS CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 92. AMERICAS CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 93. AMERICAS CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 94. AMERICAS CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 95. NORTH AMERICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. NORTH AMERICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 97. NORTH AMERICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2032 (USD MILLION)
TABLE 98. NORTH AMERICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2032 (USD MILLION)
TABLE 99. NORTH AMERICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2032 (USD MILLION)
TABLE 100. NORTH AMERICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 101. NORTH AMERICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 102. NORTH AMERICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 103. NORTH AMERICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 104. LATIN AMERICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. LATIN AMERICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 106. LATIN AMERICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2032 (USD MILLION)
TABLE 107. LATIN AMERICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2032 (USD MILLION)
TABLE 108. LATIN AMERICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2032 (USD MILLION)
TABLE 109. LATIN AMERICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 110. LATIN AMERICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 111. LATIN AMERICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 112. LATIN AMERICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2032 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2032 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2032 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 122. EUROPE CYTOMEGALOVIRUS TESTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. EUROPE CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 124. EUROPE CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2032 (USD MILLION)
TABLE 125. EUROPE CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2032 (USD MILLION)
TABLE 126. EUROPE CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2032 (USD MILLION)
TABLE 127. EUROPE CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 128. EUROPE CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 129. EUROPE CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 130. EUROPE CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 131. MIDDLE EAST CYTOMEGALOVIRUS TESTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 132. MIDDLE EAST CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 133. MIDDLE EAST CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2032 (USD MILLION)
TABLE 134. MIDDLE EAST CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2032 (USD MILLION)
TABLE 135. MIDDLE EAST CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2032 (USD MILLION)
TABLE 136. MIDDLE EAST CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 137. MIDDLE EAST CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 138. MIDDLE EAST CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 139. MIDDLE EAST CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 140. AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 142. AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2032 (USD MILLION)
TABLE 143. AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2032 (USD MILLION)
TABLE 144. AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2032 (USD MILLION)
TABLE 145. AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 146. AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 147. AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 148. AFRICA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 149. ASIA-PACIFIC CYTOMEGALOVIRUS TESTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 150. ASIA-PACIFIC CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 151. ASIA-PACIFIC CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2032 (USD MILLION)
TABLE 152. ASIA-PACIFIC CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2032 (USD MILLION)
TABLE 153. ASIA-PACIFIC CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2032 (USD MILLION)
TABLE 154. ASIA-PACIFIC CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 155. ASIA-PACIFIC CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 156. ASIA-PACIFIC CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 157. ASIA-PACIFIC CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 159. ASEAN CYTOMEGALOVIRUS TESTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 160. ASEAN CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 161. ASEAN CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2032 (USD MILLION)
TABLE 162. ASEAN CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2032 (USD MILLION)
TABLE 163. ASEAN CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2032 (USD MILLION)
TABLE 164. ASEAN CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 165. ASEAN CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 166. ASEAN CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 167. ASEAN CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 168. GCC CYTOMEGALOVIRUS TESTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 169. GCC CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 170. GCC CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2032 (USD MILLION)
TABLE 171. GCC CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2032 (USD MILLION)
TABLE 172. GCC CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2032 (USD MILLION)
TABLE 173. GCC CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 174. GCC CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 175. GCC CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 176. GCC CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 177. EUROPEAN UNION CYTOMEGALOVIRUS TESTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 178. EUROPEAN UNION CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 179. EUROPEAN UNION CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2032 (USD MILLION)
TABLE 180. EUROPEAN UNION CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2032 (USD MILLION)
TABLE 181. EUROPEAN UNION CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2032 (USD MILLION)
TABLE 182. EUROPEAN UNION CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 183. EUROPEAN UNION CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 184. EUROPEAN UNION CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 185. EUROPEAN UNION CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 186. BRICS CYTOMEGALOVIRUS TESTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 187. BRICS CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 188. BRICS CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2032 (USD MILLION)
TABLE 189. BRICS CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2032 (USD MILLION)
TABLE 190. BRICS CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2032 (USD MILLION)
TABLE 191. BRICS CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 192. BRICS CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 193. BRICS CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 194. BRICS CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 195. G7 CYTOMEGALOVIRUS TESTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 196. G7 CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 197. G7 CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2032 (USD MILLION)
TABLE 198. G7 CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2032 (USD MILLION)
TABLE 199. G7 CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2032 (USD MILLION)
TABLE 200. G7 CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 201. G7 CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 202. G7 CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 203. G7 CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 204. NATO CYTOMEGALOVIRUS TESTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 205. NATO CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 206. NATO CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2032 (USD MILLION)
TABLE 207. NATO CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2032 (USD MILLION)
TABLE 208. NATO CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2032 (USD MILLION)
TABLE 209. NATO CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 210. NATO CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 211. NATO CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 212. NATO CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 213. GLOBAL CYTOMEGALOVIRUS TESTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 214. UNITED STATES CYTOMEGALOVIRUS TESTS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 215. UNITED STATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 216. UNITED STATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2032 (USD MILLION)
TABLE 217. UNITED STATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2032 (USD MILLION)
TABLE 218. UNITED STATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2032 (USD MILLION)
TABLE 219. UNITED STATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 220. UNITED STATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 221. UNITED STATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 222. UNITED STATES CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 223. CHINA CYTOMEGALOVIRUS TESTS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 224. CHINA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 225. CHINA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY ANTIGEN DETECTION TEST, 2018-2032 (USD MILLION)
TABLE 226. CHINA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TEST, 2018-2032 (USD MILLION)
TABLE 227. CHINA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SEROLOGICAL ASSAY, 2018-2032 (USD MILLION)
TABLE 228. CHINA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 229. CHINA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 230. CHINA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 231. CHINA CYTOMEGALOVIRUS TESTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Cytomegalovirus Tests market report include:
  • Abbexa Ltd.
  • Abbott Laboratories
  • Accubiotech Co., Ltd
  • AdvaCare Pharma USA
  • Agilent Technologies, Inc.
  • Atlas Medical GmbH
  • Bio-Rad Laboratories, Inc.
  • Biogenix Inc. Pvt. Ltd.
  • CLONIT srl
  • Creative Diagnostics
  • CTK Biotech Inc. by SSI Diagnostica A/S
  • Diasorin S.p.A.
  • Elabscience Bionovation Inc.
  • F. Hoffmann-La Roche Ltd.
  • Hangzhou Realy Tech Co., Ltd.
  • Intec Products, Inc.
  • IQ Products B.V.
  • Jiangsu Macro & Micro-Test Med-Tech Co., Ltd.
  • Meridian Bioscience, Inc. by SD Biosensor
  • Thermo Fisher Scientific Inc

Table Information

Report AttributeDetails
No. of Pages187
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 788.11 Million
Forecasted Market Value ( USD ) by 2032 $ 1290 Million
Compound Annual Growth Rate8.4%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

2025 World Cytomegalovirus (CMV) Testing in 90 Countries - Five-Year Volume and Sales Forecasts by Country, Competitive Analysis, Diagnostic Assays and Test Methods - Product Image

2025 World Cytomegalovirus (CMV) Testing in 90 Countries - Five-Year Volume and Sales Forecasts by Country, Competitive Analysis, Diagnostic Assays and Test Methods

  • Report
  • Global
From
Cytomegalovirus Treatment Market - Global Forecast 2026-2032 - Product Image

Cytomegalovirus Treatment Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Cytomegalovirus (CMV) Tests Market Size By Segments, Share, Regulatory, Reimbursement, And Forecast To 2036 - Product Image

Cytomegalovirus (CMV) Tests Market Size By Segments, Share, Regulatory, Reimbursement, And Forecast To 2036

  • Report
  • 52 Pages
  • Global
From
Cytomegalovirus Infection - Pipeline Insight, 2025 - Product Image

Cytomegalovirus Infection - Pipeline Insight, 2025

  • Clinical Trials
  • 80 Pages
  • Global
From
Foscarnet Sodium Market - Global Forecast 2026-2032 - Product Image

Foscarnet Sodium Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From

About the Cytomegalovirus Test Market

The Cytomegalovirus Test is a type of infectious disease test used to detect the presence of the cytomegalovirus (CMV) in a patient's body. CMV is a common virus that can cause serious health problems in people with weakened immune systems. The test is used to diagnose CMV infection, monitor the progression of the infection, and determine the effectiveness of treatment. It is also used to screen pregnant women for CMV infection, as it can cause birth defects if the mother is infected. The Cytomegalovirus Test market is composed of a variety of diagnostic companies that offer tests for CMV. These companies provide a range of products, including ELISA kits, PCR kits, and rapid tests. Some of the companies in the market include Abbott, Bio-Rad, Roche, Siemens, and Thermo Fisher Scientific. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.